Patents by Inventor Anton Peterson

Anton Peterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS WINDOW BASED ON DEFECT PROBABILITY
    Publication number: 20240126181
    Abstract: A method including obtaining (i) measurements of a parameter of the feature, (ii) data related to a process variable of a patterning process, (iii) a functional behavior of the parameter defined as a function of the process variable based on the measurements of the parameter and the data related to the process variable, (iv) measurements of a failure rate of the feature, and (v) a probability density function of the process variable for a setting of the process variable, converting the probability density function of the process variable to a probability density function of the parameter based on a conversion function, where the conversion function is determined based on the function of the process variable, and determining a parameter limit of the parameter based on the probability density function of the parameter and the measurements of the failure rate.
    Type: Application
    Filed: November 16, 2023
    Publication date: April 18, 2024
    Applicant: ASML NETHERLANDS B.V.
    Inventors: Abraham SLACHTER, Stefan HUNSCHE, Wim Tjibbo TEL, Anton Bernhard VAN OOSTEN, Koenraad VAN INGEN SCHENAU, Gijsbert RISPENS, Brennan PETERSON
  • Crystalline polymorphs of Bruton's tyrosine kinase inhibitors
    Patent number: 11820760
    Abstract: Provided are crystalline forms of (R)-1-(tert-butyl)-N-(8-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2-(oxetan-3-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-yl)-1H-1,2,3-triazole-4-carboxamide, pharmaceutical compositions, methods of use and methods of making thereof.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: November 21, 2023
    Assignee: BIOGEN MA INC.
    Inventors: Fengmei Zheng, Anton Peterson, Kalyan Vasudevan, Chaomin Li, Daniel B. Patience, Yiqing Lin
  • CRYSTALLINE POLYMORPHS OF BRUTON'S TYROSINE KINASE INHIBITORS
    Publication number: 20210387972
    Abstract: Provided are crystalline forms of (R)-1-(tert-butyl)-N-(8-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2-(oxetan-3-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-yl)-1H-1,2,3-triazole-4-carboxamide, pharmaceutical compositions, methods of use and methods of making thereof.
    Type: Application
    Filed: October 15, 2019
    Publication date: December 16, 2021
    Applicant: Biogen MA Inc.
    Inventors: Fengmei ZHENG, Anton PETERSON, Kalyan VASUDEVAN, Chaomin LI, Daniel B. PATIENCE, Yiqing LIN
  • Crystalline form of a proteasome inhibitor
    Patent number: 10072029
    Abstract: The present disclosure relates to a novel crystalline form of a proteasome inhibitor, and to the processes for the preparation thereof. The novel crystalline form according to the disclosure may be used in the preparation of pharmaceutical compositions for the treatment of cancer.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: September 11, 2018
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Marianne Langston, Debra Mazaik, Eric Elliott, Anton Peterson, Patricia Andres, Jing Teng
  • NOVEL CRYSTALLINE FORM OF A PROTEASOME INHIBITOR
    Publication number: 20180044356
    Abstract: The present disclosure relates to a novel crystalline form of a proteasome inhibitor, and to the processes for the preparation thereof. The novel crystalline form according to the disclosure may be used in the preparation of pharmaceutical compositions for the treatment of cancer.
    Type: Application
    Filed: February 10, 2016
    Publication date: February 15, 2018
    Inventors: Marianne Langston, Debra Mazaik, Eric Elliott, Anton Peterson, Patricia Andres, Jing Teng